Dr. Mauro Ferrari is the President and CEO of The Methodist Hospital Research Institute, and holds the Ernest Cockrell Jr. Distinguished Endowed Chair. He is also the President of The Alliance for NanoHealth. Dr. Ferrari is an internationally recognized expert in nanomedicine and biomedical nanotechnology. He was trained in mathematics, engineering, and medicine.
Prior to assuming leadership of TMHRI, Dr. Ferrari was Professor and Chairman of The Department of NanoMedicine and Biomedical Engineering (nBME) at The University of Texas Health Science Center at Houston, Professor of Experimental Therapeutics at the MD Anderson Cancer Center, Adjunct Professor of Bioengineering at Rice University, and Adjoint Professor of Biomedical Engineering at the University of Texas in Austin. His previous academic appointments include professorships at UC Berkeley and Ohio State University.
From 2003 to 2005, he served as Special Expert on Nanotechnology and Eminent Scholar at The National Cancer Institute, where he led in the development of the NCI’s program in Nanotechnology, which remains the largest program in NanoMedicine in the world. Dr. Ferrari has been serving as the Editor-in-Chief for “Biomedical Microdevices: BioMEMS and Biomedical Nanotechnology” since 1997.
Dr. Ferrari holds more than 30 U.S. and International patents and has founded several startup companies, including Leonardo and NanoMedical Systems. He serves on the Board of Directors of Arrowhead Research Corporation (NASDAQ:ARWR).
He has published approximately 200 peer-reviewed articles and received many national and international awards including the James A. Shannon Director’s Award from the National Institutes of Health, the Department of Defense (DOD) Breast Cancer Research Program (BCRP) Innovator Award in 2008, the National Young Investigator Award of the National Science Foundation from 1993 to 1998, and the Wallace H. Coulter Award for Innovation and Entrepreneurship in 1999.
He is also an elected Fellow of the American Institute of Medical and Biological Engineering (AIMBE), the American Association for the Advancement of Science (AAAS), and the American Society of Mechanical Engineers (ASME). He was nominated Knight of the Order of Merit of the Italian Republic by the President of Italy. Dr Ferrari was also the first recipient of a Research Superiority Award from the Emerging Technology Fund of the State of Texas.